Stoke Therapeutics, Inc.
USD32.77
+0.38 (+1.17%)
CEO
Ian F. Smith
IPO Date
2019-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$32.90
Prev. Close
$32.39
Day Low
$32.50
Day High
$33.10
52W Low
$11.19
52W High
$40.22
Market Cap
$2.04B
Volume
0.17M
| -6.7 |
| 31 Dec 2023 | FY | 100.0% | -1192.5% | -65.6% | -45.9% | 0.01 | 6.99 | -2.2 |
| 31 Dec 2022 | FY | 100.0% | -814.7% | -54.7% | -39.5% | 0.01 | 7.77 | -3.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -39.4% | -35.9% | 0.01 | 13.37 | -10.3 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -18.3% | -17.5% | 0.00 | 25.73 | -39.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -14.4% | -14.1% | 0.00 | 55.12 | -15.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -11.9% | -11.6% | 0.00 | 43.03 | -48.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 430.2% | -227.9% | -2.32 | 0.51 | -108.2 |
| -8.0 |
| 30 Sept 2025 | Q3 | 90.7% | -360.7% | -12.4% | -10.6% | 0.01 | 6.53 | -9.0 |
| 30 Jun 2025 | Q2 | 100.0% | -170.0% | -7.0% | -6.1% | 0.01 | 6.98 | -7.1 |
| 31 Mar 2025 | Q1 | 100.0% | 71.2% | 32.2% | 27.7% | 0.01 | 8.41 | 0.9 |
| 31 Dec 2024 | Q4 | 100.0% | -46.4% | -4.6% | -3.9% | 0.01 | 5.81 | -15.0 |
| 30 Sept 2024 | Q3 | 100.0% | -540.0% | -11.4% | -9.0% | 0.01 | 5.09 | -6.5 |
| 30 Jun 2024 | Q2 | 77.0% | -531.9% | -10.6% | -8.3% | 0.01 | 6.67 | -7.5 |
| 31 Mar 2024 | Q1 | 73.6% | -625.6% | -18.8% | -12.9% | 0.02 | 5.43 | -5.9 |
| 31 Dec 2023 | Q4 | 56.6% | -962.1% | -16.9% | -11.8% | 0.01 | 6.99 | -2.2 |